Table 3 Cox regression hazard model including the maximum grade of total adverse events within the first 6 months for overall survival.
Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|
Characteristics | HR | 95% CI | P | HR | 95% CI | P |
Adverse events | ||||||
Grade 0 | 1 (Reference) | 1 (Reference) | ||||
Grade 1 | 0.81 | (0.64–1.03) | 0.089 | 0.77 | (0.61–0.98) | 0.035 |
Grade 2 | 0.74 | (0.59–0.92) | 0.0066 | 0.70 | (0.56–0.87) | 0.0017 |
Grade 3 | 0.74 | (0.57–0.96) | 0.021 | 0.69 | (0.53–0.91) | 0.0074 |
Grade 4 | 1.49 | (0.83–2.69) | 0.18 | 1.12 | (0.62–2.04) | 0.71 |
Age, years | ||||||
<70 | 1 (Reference) | 1 (Reference) | ||||
≥70 | 1.34 | (1.13–1.59) | 0.0008 | 1.43 | (1.21–1.71) | <0.0001 |
Sex | ||||||
Male | 1 (Reference) | 1 (Reference) | ||||
Female | 0.83 | (0.70–0.97) | 0.024 | 0.83 | (0.70–0.99) | 0.034 |
BMI, kg/m2 | ||||||
18.5−25 | 1 (Reference) | 1 (Reference) | ||||
<18.5 | 0.96 | (0.76–1.22) | 0.75 | 0.94 | (0.74–1.20) | 0.64 |
25> | 0.82 | (0.65–1.04) | 0.11 | 0.82 | (0.65–1.04) | 0.10 |
PS (ECOG) | ||||||
0 | 1 (Reference) | 1 (Reference) | ||||
1, 2 | 0.78 | (0.48–1.29) | 0.33 | 0.74 | (0.45–1.22) | 0.24 |
Tumour location | ||||||
Colon | 1 (Reference) | 1 (Reference) | ||||
Rectum | 1.21 | (1.03–1.42) | 0.024 | 1.38 | (1.16–1.63) | 0.0002 |
Histology | ||||||
Well to moderate | 1 (Reference) | 1 (Reference) | ||||
Other | 2.09 | (1.63–2.68) | <0.0001 | 1.79 | (1.39–2.30) | <0.0001 |
pT-stagea | ||||||
T1−3 | 1 (Reference) | 1 (Reference) | ||||
T4 | 1.94 | (1.64–2.28) | <0.0001 | 2.03 | (1.72–2.40) | <0.0001 |
pN-stagea | ||||||
N0 | 1 (Reference) | 1 (Reference) | ||||
N1 | 1.97 | (1.42–2.74) | <0.0001 | 2.65 | (1.90–3.70) | <0.0001 |
N2 | 3.97 | (2.84–5.57) | <0.0001 | 4.71 | (3.35–6.62) | <0.0001 |